MedPath

Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension

Not Applicable
Completed
Conditions
Hypertension, Pulmonary
Registration Number
NCT04697875
Lead Sponsor
University of Zurich
Brief Summary

To study hemodynamic effects of acute normobaric hypoxia during exercise in patients with pulmonary hypertension in a single-center randomized controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Informed consent as documented by signature (Appendix Informed Consent Form)
  • PH class I (PAH) or IV (CTEPH) diagnosed according to guidelines: mean pulmonary artery pressure >20 mmHg, pulmonary vascular resistance ≥3 wood units, pulmonary arterial wedge pressure ≤15 mmHg during baseline measures at the diagnostic right-heart catheterization
Exclusion Criteria
  • resting partial pressure of oxygen <8 kilopascal at Zürich altitude on ambient air
  • exposure to an altitude >1000 m for ≥3 nights during the last 2 weeks before the study
  • inability to follow the procedures of the study
  • patients who take nitrates
  • other clinically significant concomitant end-stage disease (e.g., renal failure, hepatic dysfunction)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
mean pulmonary artery pressure (mPAP) / cardiac output (CO)2 hours

Difference in mPAP/CO during exercise between tests under hypoxia vs. normoxia

Secondary Outcome Measures
NameTimeMethod
Differences in right atrial pressure2 hours

Differences in right atrial pressure at rest and during exercise, with normoxia/hypoxia

Differences in blood pressure2 hours

Differences in blood pressure at rest and during exercise, with normoxia/hypoxia

Differences in pulmonary arterial pressure2 hours

Differences in pulmonary arterial pressure at rest and during exercise, with normoxia/hypoxia

Pulmonary vascular resistance2 hours

Differences in pulmonary vascular resistance at rest and during exercise, with normoxia/hypoxia

Differences in pulmonary artery wedge pressure2 hours

Differences in pulmonary artery wedge pressure at rest and during exercise, with normoxia/hypoxia

Differences in heart rate2 hours

Differences in heart rate at rest and during exercise, with normoxia/hypoxia

Differences in cardiac output2 hours

Differences in cardiac output at rest and during exercise, with normoxia/hypoxia

Differences in oxygen saturation2 hours

Differences in oxygen saturation at rest and during exercise, with normoxia/hypoxia

Differences in arterial blood gases2 hours

Differences in arterial blood gases at rest and during exercise, with normoxia/hypoxia

Differences in mixed venous blood gases2 hours

Differences in mixed venous blood gases at rest and during exercise, with normoxia/hypoxia

Differences in cerebral tissue oxygenation2 hours

Differences in cerebral tissue oxygenation at rest and during exercise, with normoxia/hypoxia

Differences in symptoms (Borg dyspnoea)2 hours

Differences in symptoms (Borg dyspnoea) at rest and during exercise, with normoxia/hypoxia

Differences in mixed venous oxygen saturation2 hours

Differences in mixed venous oxygen saturation at rest and during exercise, with normoxia/hypoxia

Differences in muscle tissue oxygenation2 hours

Differences in muscle tissue oxygenation at rest and during exercise, with normoxia/hypoxia

Differences in symptoms (Borg leg effort)2 hours

Differences in symptoms (Borg leg effort) at rest and during exercise, with normoxia/hypoxia

Trial Locations

Locations (1)

UniversityHospital Zurich, Department of Pulmonology

🇨🇭

Zurich, Switzerland

UniversityHospital Zurich, Department of Pulmonology
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.